These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 11453350)
1. Viruses to the rescue: p53-based therapies in the fight against cancer. Hibma M; Braithwaite A N Z Med J; 2001 Jun; 114(1133):266-9. PubMed ID: 11453350 [No Abstract] [Full Text] [Related]
2. Living with p53, dying of p53. Aylon Y; Oren M Cell; 2007 Aug; 130(4):597-600. PubMed ID: 17719538 [TBL] [Abstract][Full Text] [Related]
3. Cancer therapy and apoptosis. Inoue S Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():102-14. PubMed ID: 9210892 [No Abstract] [Full Text] [Related]
4. Cancer therapy based on p53. McCormick F Cancer J Sci Am; 1999; 5(3):139-44. PubMed ID: 10367167 [No Abstract] [Full Text] [Related]
5. p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor? Levesque AA; Eastman A Carcinogenesis; 2007 Jan; 28(1):13-20. PubMed ID: 17088261 [TBL] [Abstract][Full Text] [Related]
6. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy. Wiman KG Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952 [TBL] [Abstract][Full Text] [Related]
7. The genetics of the p53 pathway, apoptosis and cancer therapy. Vazquez A; Bond EE; Levine AJ; Bond GL Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449 [TBL] [Abstract][Full Text] [Related]
9. Structural and functional basis for therapeutic modulation of p53 signaling. Bassett EA; Wang W; Rastinejad F; El-Deiry WS Clin Cancer Res; 2008 Oct; 14(20):6376-86. PubMed ID: 18927276 [TBL] [Abstract][Full Text] [Related]
10. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma. Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070 [TBL] [Abstract][Full Text] [Related]
11. Targeting p53 for enhanced radio- and chemo-sensitivity. Lu C; El-Deiry WS Apoptosis; 2009 Apr; 14(4):597-606. PubMed ID: 19259822 [TBL] [Abstract][Full Text] [Related]
12. [Relevance of p53 protein and its mutations for novel strategies in cancer therapy]. Müller P; Nenutil R; Vojtĕsek B Cas Lek Cesk; 2004; 143(5):313-7. PubMed ID: 15305766 [TBL] [Abstract][Full Text] [Related]
13. Virus-mediated killing of cells that lack p53 activity. Raj K; Ogston P; Beard P Nature; 2001 Aug; 412(6850):914-7. PubMed ID: 11528480 [TBL] [Abstract][Full Text] [Related]
14. Cell cycle checkpoints and their impact on anticancer therapeutic strategies. Eastman A J Cell Biochem; 2004 Feb; 91(2):223-31. PubMed ID: 14743382 [TBL] [Abstract][Full Text] [Related]
15. p53 mutation heterogeneity in cancer. Soussi T; Lozano G Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939 [TBL] [Abstract][Full Text] [Related]
16. p53 modulation of the DNA damage response. Helton ES; Chen X J Cell Biochem; 2007 Mar; 100(4):883-96. PubMed ID: 17031865 [TBL] [Abstract][Full Text] [Related]
18. Exploiting the p53 pathway for the diagnosis and therapy of human cancer. Lane DP Cold Spring Harb Symp Quant Biol; 2005; 70():489-97. PubMed ID: 16869788 [TBL] [Abstract][Full Text] [Related]
19. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death]. Mendoza-Rodríguez CA; Cerbón MA Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714 [TBL] [Abstract][Full Text] [Related]
20. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate. Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]